Donna Shiroma - 30 Nov 2023 Form 4 Insider Report for AVITA Medical, Inc. (RCEL)

Role: General Counsel
Signature: /s/ Donna Shiroma
Issuer symbol: RCEL
Transactions as of: 30 Nov 2023
Net transactions value: +$13,309
Form type: 4
Filing time: 05 Jan 2024, 17:51:10 UTC
Previous filing: 08 Sep 2023
Next filing: 03 Jun 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RCEL	Common Stock	Award	$13,309	+1,469	+3.5%	$9.06	43,726	30 Nov 2023	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RCEL	Stock Options (Right to Buy)	Award	$0	+100,000		$0.000000	100,000	03 Jan 2024	Common Stock	100,000	$12.64	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were acquired under the AVITA Medical, Inc. Employee Share Purchase Plan ("ESPP") for the ESPP purchase which began July 1, 2023 and ended November 30, 2023 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Company's stock on November 30, 2023 (the purchase date of the offering period).
F2	Includes unvested RSUs
F3	These Stock Options vest in three equal annual installments beginning the first anniversary of the grant date.